TABLEĀ 2.
Molecular type | No. of isolates in DBa | No. of isolates from known clinical background | No. (%) immunocompetent (previously healthy) | No. (%) immunocompromised |
Underlying issues other than HIV (no. of patients) | |
---|---|---|---|---|---|---|
HIV+ | Other | |||||
VGI | 354 | 40 | 20 (50) | 11 (27.5) | 9 (22.5) | Cirrhosis (1), SLE (3), tumor-like structure (1), pregnancy (1), CML (1), diabetes (1), CD4 lymphopenia (1) |
VGII | 862 | 112 | 55 (49.1) | 52 (46.4) | 5 (4.5) | SLE (1), diabetes (2), alcoholic (1), MLS (1) |
VGIII | 210 | 15 | 7 (46.6) | 1 (6.6) | 7 (46.6) | Hepatoma (1), diabetes (1), depression (1), hypertension (1), paracoccidioidomycosis (1), strongyloidiasis (1), malnutrition (1), immunosuppressed (4) |
VGIV | 28 | 12 | 3 (25) | 8 (66.6) | 1 (8.3) | Diabetes (1) |
Total | 1454 | 179 | 85 (47.4) | 72 (40.2) | 22 (12.2) |
DB, database; SLE, systemic lupus erythematosus; CML, chronic myelogenous leukemia; MLS, microphthalmia syndrome.